Progyny, Inc. (PGNY) Financial Statements
Industry: Misc Health & Allied Services (Other) (Services)
In fiscal 2025, Progyny reported revenue of $1.29B, up 10.4% from $1.17B the year before. Net income was $58.5M (a 4.5% net margin), or $0.65 per diluted share. Gross margin was 23.6% and operating margin was 6.6%. Operating activities generated $210.2M of cash, leaving $191.8M of free cash flow. At fiscal year end, Progyny held $742.4M in total assets against $226.4M in total liabilities, including $112.2M of cash and equivalents.
Open the full interactive Progyny financials → Quarterly statements, key ratios, valuation history and price charts.
Progyny Key Stats
| Share Price | $27.39 |
|---|---|
| Market Cap | $2.25B |
| P/E Ratio | 42.1 |
| Revenue YoY Growth | +10.4% |
| 52-Week Range | $16.30 – $32.36 |
| Shares Outstanding | 78.2 million (basic, 2026 Q2) |
Progyny Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $344.9M | $500.6M | $786.9M | $1.09B | $1.17B | $1.29B |
| Cost of Goods Sold | $274.8M | $388.5M | $619.6M | $849.8M | $913.9M | $984.2M |
| Gross Profit | $70.1M | $112.1M | $167.3M | $238.8M | $253.4M | $304.5M |
| Operating Income | $8.3M | $32.3M | $23.3M | $62.2M | $67.5M | $85.3M |
| Pre-Tax Income | $8.7M | $32.4M | $24.4M | $70.7M | $83.2M | $95.4M |
| Income Tax | -$37.8M | -$33.3M | -$5.9M | $8.7M | $28.9M | $36.9M |
| Net Income | $46.5M | $65.8M | $30.4M | $62.0M | $54.3M | $58.5M |
| Diluted EPS | $0.47 | $0.66 | $0.30 | $0.62 | $0.57 | $0.65 |
Progyny Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $313.3M | $318.4M | $328.5M | $350.5M |
| Net Income | $13.9M | $12.5M | $24.2M | $28.1M |
| Diluted EPS | $0.15 | $0.14 | $0.29 | $0.34 |
Progyny Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $70.3M | $91.4M | $120.1M | $97.3M | $162.3M | $112.2M |
| Current Assets | $190.2M | $258.5M | $433.9M | $640.4M | $472.7M | $551.8M |
| Total Assets | $253.9M | $358.1M | $543.0M | $756.6M | $607.1M | $742.4M |
| Current Liabilities | $77.8M | $98.8M | $159.5M | $185.9M | $168.6M | $202.4M |
| Total Liabilities | $87.0M | $106.2M | $166.0M | $203.2M | $185.0M | $226.4M |
| Shareholders' Equity | $166.9M | $251.8M | $377.0M | $553.4M | $422.1M | $516.0M |
Progyny Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $36.2M | $26.0M | $80.4M | $188.8M | $179.1M | $210.2M |
| Cash From Investing | -$40.0M | $8.8M | -$43.9M | -$200.5M | $195.8M | -$159.0M |
| Cash From Financing | -$6.2M | -$13.7M | -$7.9M | -$11.1M | -$309.9M | -$99.4M |
| Free Cash Flow | $35.2M | $23.9M | $77.2M | $185.2M | $173.7M | $191.8M |
Figures from Progyny's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Progyny financials page for every line item.
Progyny Company Profile
| Ticker | PGNY |
|---|---|
| Exchange | Nasdaq |
| Industry | Misc Health & Allied Services (Other) (Services) |
| Headquarters | New York, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001551306 |
Frequently Asked Questions
What was Progyny's revenue in fiscal 2025?
Progyny (PGNY) reported revenue of $1.29B for fiscal 2025.
What is Progyny's annual revenue history?
Progyny's annual revenue by fiscal year: 2020: $344.9M; 2021: $500.6M; 2022: $786.9M; 2023: $1.09B; 2024: $1.17B; 2025: $1.29B.
What was Progyny's net income in fiscal 2025?
Progyny reported net income of $58.5M for fiscal 2025.
What was Progyny's earnings per share (EPS) in fiscal 2025?
Progyny's diluted EPS was $0.65 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Progyny generate in fiscal 2025?
Progyny generated $191.8M of free cash flow in fiscal 2025.
What was Progyny's revenue last quarter?
In its most recent reported quarter (2026 Q2), Progyny reported revenue of $350.5M.
How many shares of Progyny are outstanding?
Progyny reported a weighted average of 78.2 million basic shares outstanding in 2026 Q2.
What is Progyny's market cap?
Based on its latest closing price, Progyny (PGNY) has a market capitalization of about $2.25B.
When does Progyny's fiscal year end?
Progyny's fiscal year end, as registered with the SEC, is December 31.
Where is Progyny headquartered?
Progyny lists its business address in New York, New York in its SEC filings.
Progyny Competitors & Similar Companies
See all 9 Misc Health & Allied Services (Other) (Services) companies →